Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TITANIC - Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes

NCT07713498 is registered in ClinicalTrials.gov with Franciscus Gasthuis as lead sponsor.

NCT NCT07713498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07713498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TITANIC - Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes
Lead sponsor
Franciscus Gasthuis
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 1, 2026
Completion date
October 31, 2027
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma